Evolent Health's Wild Ride: Is It a Buy?

Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Saturdays

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Evolent Health's stock dipped after a lukewarm rating from Stephens, but don't write them off yet! Fresh off a $113M primary care business sale, Evolent's refocusing on specialty conditions and paying down debt. Is this a buying opportunity or a warning sign? We break down the volatility, the long-term investor outlook, and where the smart money's heading next – think AI-powered healthcare tech. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site